MedPath

WEST-WARD PHARMACEUTICAL

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$21.9B
Website

Clinical Trials

4

Active:0
Completed:3

Trial Phases

3 Phases

Phase 3:2
Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (50.0%)
Not Applicable
1 (25.0%)
Phase 4
1 (25.0%)

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)

Not Applicable
Completed
Conditions
Asthma
Interventions
First Posted Date
2018-05-24
Last Posted Date
2019-11-29
Lead Sponsor
West-Ward Pharmaceutical
Target Recruit Count
1556
Registration Number
NCT03535870
Locations
🇺🇸

West-Ward Research Site #1, Las Vegas, Nevada, United States

Study of Oral Morphine Sulfate Administration in Pediatric Subjects

Phase 3
Completed
Conditions
Pain, Postoperative
Interventions
First Posted Date
2018-02-12
Last Posted Date
2019-09-26
Lead Sponsor
West-Ward Pharmaceutical
Target Recruit Count
51
Registration Number
NCT03429400
Locations
🇺🇸

Site 105, Sheffield, Alabama, United States

Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV

Phase 4
Recruiting
Conditions
Hypotension
Interventions
First Posted Date
2014-12-23
Last Posted Date
2024-07-23
Lead Sponsor
West-Ward Pharmaceutical
Target Recruit Count
100
Registration Number
NCT02323399
Locations
🇺🇸

Alfred I. DuPont Hospital for Children, Wilmington, Delaware, United States

🇺🇸

Children's National Medical Center, Washington, District of Columbia, United States

🇺🇸

Jackson Memorial Hospital, Miami, Florida, United States

and more 7 locations

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Phase 3
Completed
Conditions
Epilepsy
Interventions
Drug: Placebo tablet
First Posted Date
2011-01-27
Last Posted Date
2017-11-14
Lead Sponsor
West-Ward Pharmaceutical
Target Recruit Count
314
Registration Number
NCT01284556
Locations
🇺🇸

Bluegrass Epilepsy Research, Lexington, Kentucky, United States

🇺🇸

Lynn Health Science Institute, Oklahoma City, Oklahoma, United States

🇵🇷

Centro Neurodiagnostico, Rio Piedras, Puerto Rico

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.